- Home
- TSHA vs APEI Comparison
TSHA vs APEI Comparison
Compare TSHA & APEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- APEI
- Stock Information
- Founded
- TSHA 2019
- APEI 1991
- Country
- TSHA United States
- APEI United States
- Employees
- TSHA N/A
- APEI N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- APEI Other Consumer Services
- Sector
- TSHA Health Care
- APEI Consumer Discretionary
- Exchange
- TSHA Nasdaq
- APEI Nasdaq
- Market Cap
- TSHA 334.1M
- APEI 416.2M
- IPO Year
- TSHA 2020
- APEI 2007
- Fundamental
- Price
- TSHA $1.72
- APEI $21.10
- Analyst Decision
- TSHA Strong Buy
- APEI Buy
- Analyst Count
- TSHA 8
- APEI 4
- Target Price
- TSHA $6.63
- APEI $24.33
- AVG Volume (30 Days)
- TSHA 1.5M
- APEI 117.3K
- Earning Date
- TSHA 02-26-2025
- APEI 03-06-2025
- Dividend Yield
- TSHA N/A
- APEI N/A
- EPS Growth
- TSHA N/A
- APEI N/A
- EPS
- TSHA N/A
- APEI 0.55
- Revenue
- TSHA $8,333,000.00
- APEI $624,559,000.00
- Revenue This Year
- TSHA N/A
- APEI $5.90
- Revenue Next Year
- TSHA N/A
- APEI $4.20
- P/E Ratio
- TSHA N/A
- APEI $39.69
- Revenue Growth
- TSHA N/A
- APEI 4.00
- 52 Week Low
- TSHA $1.19
- APEI $11.80
- 52 Week High
- TSHA $4.32
- APEI $25.60
- Technical
- Relative Strength Index (RSI)
- TSHA 54.31
- APEI 47.72
- Support Level
- TSHA $1.66
- APEI $18.77
- Resistance Level
- TSHA $1.77
- APEI $23.62
- Average True Range (ATR)
- TSHA 0.11
- APEI 1.29
- MACD
- TSHA 0.01
- APEI 0.09
- Stochastic Oscillator
- TSHA 47.62
- APEI 34.11
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About APEI American Public Education Inc.
American Public Education Inc provides online and campus based postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.